Cardiovascular Risk Assessment in HIV-Infected Patients

1. World Health Organization. HIV data and statistics. Global HIV, Hepatitis and STIs Programme2020 (cited 2020); Available from: https://www.who.int/hiv/data/en/.Search in Google Scholar

2. Feinstein MJ, Hsue PY, Benjamin LA, Bloomfield GS, Currier JS, Freiberg MS, et al. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association. Circulation. 2019 Jul 9;140(2):E98-E124.10.1161/CIR.0000000000000695799336431154814Search in Google Scholar

3. Saad H, Ntusi NAB. HIV-Associated Cardiovascular Disease. Advances in HIV and AIDS Control. 2018, Chapter 11.10.5772/intechopen.80483Search in Google Scholar

4. Prevedel L, Morocho C, Bennett MVL, Eugenin EA. HIV-Associated Cardiovascular Disease Role of Connexin 43. Am J Pathol. 2017 Sep;187(9):1960-70.10.1016/j.ajpath.2017.05.011580950428688235Search in Google Scholar

5. Mesquita EC, Coelho LE, Amancio RT, Veloso V, Grinsztejn B, Luz P, et al. Severe infection increases cardiovascular risk among HIV-infected individuals. Bmc Infect Dis. 2019 Apr 11;19.10.1186/s12879-019-3894-6646081830975092Search in Google Scholar

6. Policarpo S, Rodrigues T, Moreira AC, Valadas E. Cardiovascular risk in HIV-infected individuals: A comparison of three risk prediction algorithms. Rev Port Cardiol. 2019 Jul;38(7):463-70.10.1016/j.repc.2019.08.00231522936Search in Google Scholar

7. Giles ML, Gartner C, Boyd MA. Smoking and HIV: what are the risks and what harm reduction strategies do we have at our disposal? Aids Res Ther. 2018 Dec 12;15.10.1186/s12981-018-0213-z629197930541577Search in Google Scholar

8. Zanetti HR, Roever L, Gonçalves A, Resende ES. Cardiovascular Complications of HIV. International Journal of Cardiovascular Sciences. 2018;31:538-43.10.5935/2359-4802.20180049Search in Google Scholar

9. Hejazi N, Rajikan R, Choong CLK, Sahar S. Metabolic abnormalities in adult HIV infected population on antiretroviral medication in Malaysia: a cross-sectional survey. Bmc Public Health. 2013 Aug 15;13.10.1186/1471-2458-13-758384434023947428Search in Google Scholar

10. Mothe B, Perez I, Domingo P, Podzamczer D, Ribera E, Curran A, et al. HIV-1 Infection in Subjects Older than 70: A Multicenter Cross-Sectional Assessment in Catalonia, Spain. Curr Hiv Res. 2009 Nov;7(6):597-600.10.2174/15701620978997369119929794Search in Google Scholar

11. Shen YZ, Wang JR, Wang ZY, Qi TK, Song W, Tang Y, et al. Prevalence of Dyslipidemia Among Antiretroviral-Naive HIV-Infected Individuals in China. Medicine. 2015 Dec;94(48).10.1097/MD.0000000000002201467421126632908Search in Google Scholar

12. Lin SP, Wu CY, Wang CB, Li TC, Ko NY, Shi ZY. Risk of diabetes mellitus in HIV-infected patients receiving highly active antiretroviral therapy A nationwide population-based study. Medicine. 2018 Sep;97(36).10.1097/MD.0000000000012268613341830200166Search in Google Scholar

13. Kaplan RC, Hanna DB, Kizer JR. Recent Insights Into Cardiovascular Disease (CVD) Risk Among HIV-Infected Adults. Curr Hiv-Aids Rep. 2016 Feb;13(1):44-52.10.1007/s11904-016-0301-4633619226910597Search in Google Scholar

14. Arcus M, Lilios G, Schroder V, Taralunga G, Stoicescu RM, Dumitru IM. Natural Compounds with Benefits Regarding the Cardiovascular Diseases. J Environ Prot Ecol. 2015;16(1):333-9.Search in Google Scholar

15. Freiberg MS, Chang CCH, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. HIV Infection and the Risk of Acute Myocardial Infarction. Jama Intern Med. 2013 Apr 22;173(8):614-22.10.1001/jamainternmed.2013.3728476679823459863Search in Google Scholar

16. Paisible AL, Chang CCH, So-Armah KA, Butt AA, Leaf DA, Budoff M, et al. HIV Infection, Cardiovascular Disease Risk Factor Profile, and Risk for Acute Myocardial Infarction. Jaids-J Acq Imm Def. 2015 Feb 1;68(2):209-16.10.1097/QAI.0000000000000419444120125588033Search in Google Scholar

17. Hsue PY, Waters DD. Heart failure in persons living with HIV infection. Curr Opin Hiv Aids. 2017 Nov;12(6):534-9.10.1097/COH.000000000000040928863015Search in Google Scholar

18. Remick J, Georgiopoulou V, Marti C, Ofotokun I, Kalogeropoulos A, Lewis W, et al. Heart Failure in Patients With Human Immunodeficiency Virus Infection Epidemiology, Pathophysiology, Treatment, and Future Research. Circulation. 2014 Apr 29;129(17):1781-9.10.1161/CIRCULATIONAHA.113.004574400634324778120Search in Google Scholar

19. Barbaro G, Silva EF. Cardiovascular complications in the acquired immunodeficiency syndrome. Rev Assoc Med Bras (1992). 2009 Sep-Oct;55(5):621-30.10.1590/S0104-4230200900050003119918668Search in Google Scholar

20. Quezada M, Martin-Carbonero L, Soriano V, Vispo E, Valencia E, Moreno V, et al. Prevalence and risk factors associated with pulmonary hypertension in HIV-infected patients on regular follow-up. Aids. 2012 Jul 17;26(11):1387-92.10.1097/QAD.0b013e328354f5a122526521Search in Google Scholar

21. Nunes H, Humbert M, Sitbon O, Morse JH, Deng Z, Knowles JA, et al. Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension. Am J Respir Crit Care Med. 2003 May 15;167(10):1433-9.10.1164/rccm.200204-330OC12615632Search in Google Scholar

22. Raggi P, Corwin C. Heart aging measured with coronary artery calcium scoring and cardiovascular risk assessment algorithms in HIV infected patients. Virulence. 2017;8(5):539-44.10.1080/21505594.2016.1212154553833627410249Search in Google Scholar

23. Myerson M, Glesby MJ. Cardiovascular Care in Patients With HIV: Springer International Publishing; 2019.10.1007/978-3-030-10451-1Search in Google Scholar

24. Triant VA, Perez J, Regan S, Massaro JM, Meigs JB, Grinspoon SK, et al. Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection. Circulation. 2018 May 22;137(21):2203-14.10.1161/CIRCULATIONAHA.117.028975615792329444987Search in Google Scholar

25. Noumegni SR, Ama VJM, Assah FK, Bigna JJ, Nansseu JR, Kameni JAM, et al. Assessment of the agreement between the Framingham and DAD risk equations for estimating cardiovascular risk in adult Africans living with HIV infection: a cross-sectional study. Trop Dis Travel Med Vaccines. 2017;3:12.10.1186/s40794-017-0055-z553100728883982Search in Google Scholar

26. Nery MW, Martelli CM, Silveira EA, de Sousa CA, Falco Mde O, de Castro Ade C, et al. Cardiovascular risk assessment: a comparison of the Framingham, PROCAM, and DAD equations in HIV-infected persons. ScientificWorldJournal. 2013;2013:969281.10.1155/2013/969281381902224228022Search in Google Scholar

27. Kim MH, Kim YS, Oh HJ, Kwon YR, Kim HW. The Association between 10-Year Atherosclerotic Cardiovascular Diseases Risk Score Calculated Using 2013 American College of Cardiology/American Heart Association Guidelines and Serum 25-Hydroxyvitamin D Level among Aged 40-79 Years in Korea: The Sixth Korea National Health and Nutrition Examination Surveys. Korean J Fam Med. 2018 May;39(3):174-9.10.4082/kjfm.2018.39.3.174597598829788706Search in Google Scholar